This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Goat Anti-Avian Leukosis Virus (ALV) Polyclonal Antibody
Product Overview
BioVenic goat polyclonal antibody is specific for avian leukosis virus. It can be applied to ELISA of avian leukosis virus.
Specifications
Target Information
Avian leukosis virus (ALV) is an oncogenic virus that affects domestic and wild birds, leading to a range of diseases including lymphoid leukosis and other forms of cancer. ALV belongs to the Retroviridae family and is characterized by its ability to integrate its genetic material into the host genome, which can result in uncontrolled cell proliferation. The virus primarily targets cells of the lymphoid lineage, leading to the development of malignant tumors. The long latency period of ALV infection makes it challenging to detect and control in poultry populations. Key proteins of ALV include the envelope glycoprotein (gp85), which is involved in viral entry and cell fusion, and reverse transcriptase, which is essential for transcribing viral RNA into DNA.
Shipping and Storage
This product is shipped with ice gel packs. Store at 4°C (up to 24 months) on receipt.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Feng, Min, et al. "Immunity to avian leukosis virus: where are we now and what should we do?." Frontiers in Immunology 7 (2016): 624.